Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in Kidney Transplantation (EPURE)
NCT02490904Phase 3Active, not recruiting
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Oct 2016
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of eplerenone in ischemia-reperfusion injury (IRI), sponsored by CHRU de Nancy - Hôpital Central. Started Oct 2016; status: active, not recruiting.
02
Drugs
eplerenone
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT02490904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02490904.